Organization Overview
Alternative names
acetylsalicylic acid (aspirin) (7 trials)
adefovir dipivoxil (hepsera) (5 trials)
allopurinol (zyloprim) (2 trials)
Anti-thymocyte Globulin (Rabbit) (Thymoglobulin) (4 trials)
arsenic trioxide (trisenox) (3 trials)
atorvastatin (lipitor) (4 trials)
bicalutamide (casodex) (5 trials)
bortezomib (velcade) (4 trials)
budesonide (rhinocort) (1 trial)
carboplatin (paraplatin) (50 trials)
celecoxib (celebrex) (7 trials)
cenegermin-bkbj (oxervate) (2 trials)
cisatracurium (nimbex) (1 trial)
clopidogrel (plavix) (1 trial)
cytarabine (cytosar-u) (8 trials)
dapagliflozin (farxiga) (1 trial)
desmopressin (ddavp) (2 trials)
dexmedetomidine (precedex) (9 trials)
esomeprazole (nexium) (4 trials)
estradiol (progynon depot) (3 trials)
etanercept (enbrel) (6 trials)
etoposide (vepesid) (19 trials)
fluorometholone (fml) (1 trial)
formoterol (foradil) (1 trial)
goserelin (zoladex) (3 trials)
hepatitis b immune globulin (human) (BayHep B) (1 trial)
infliximab (remicade) (4 trials)
insulin aspart (novolog) (1 trial)
insulin glargine (toujeo) (3 trials)
insulin human (humulin) (12 trials)
insulin lispro (humalog) (4 trials)
interferon alpha-2b (Intron-A) (19 trials)
iodixanol (visipaque) (1 trial)
lamivudine (epivir) (7 trials)
linagliptin (tradjenta) (2 trials)
liraglutide (victoza) (2 trials)
mercaptopurine (purinethol) (4 trials)
metformin (glucophage) (5 trials)
mitoxantrone (novantrone) (3 trials)
montelukast (singulair) (3 trials)
mycophenolate (myfortic) (8 trials)
pioglitazone (actos) (3 trials)
pitavastatin (livalo) (1 trial)
prednisone (meticorten) (18 trials)
propofol (diprivan) (9 trials)
ranibizumab (lucentis) (7 trials)
realgar-indigo naturalis (1 trial)
remifentanil (ultiva) (4 trials)
rituximab (rituxan) (14 trials)
rivaroxaban (xarelto) (1 trial)
saxagliptin (onglyza) (2 trials)
sevoflurane (ultane) (5 trials)
sitagliptin (januvia) (9 trials)
somatropin (protropin) (6 trials)
sorafenib (nexavar) (20 trials)
sulfasalazine (azulfidine) (2 trials)
tacrolimus (prograf) (11 trials)
tamoxifen (nolvadex) (9 trials)
telbivudine (tyzeka) (6 trials)
tenofovir (viread) (10 trials)
thalidomide (Thalomid) (9 trials)
thymalfasin (zadaxin) (4 trials)
vancomycin (Vancocin) (1 trial)
vecuronium (norcuron) (1 trial)
adalimumab (humira) (3 trials)
alemtuzumab (campath) (1 trial)
allogeneic blood cells (2 trials)
alprostadil (prostin) (2 trials)
autologous mesenchymal stem cells (15 trials)
azathioprine (imuran) (7 trials)
bevacizumab (avastin) (32 trials)
bleomycin (blenoxane) (3 trials)
busulfan (myleran) (12 trials)
capecitabine (xeloda) (52 trials)
cd25 monoclonal antibody (1 trial)
cetuximab (erbitux) (10 trials)
cisplatin (platinol) (119 trials)
cord blood hematopoietic stem cell (1 trial)
crizotinib (xalkori) (1 trial)
cyclophosphamide (cytoxan) (50 trials)
cyclosporine (sandimmune) (9 trials)
cytokine induced killer cells (4 trials)
decitabine (dacogen) (7 trials)
docetaxel (taxotere) (61 trials)
doxorubicin (Doxil) (25 trials)
doxycycline (vibramycin) (5 trials)
epirubicin (ellence) (12 trials)
erlotinib (tarceva) (10 trials)
filgrastim (neupogen) (7 trials)
fludarabine (fludara) (8 trials)
fluorouracil (efudex) (89 trials)
fulvestrant (faslodex) (7 trials)
gemcitabine (gemzar) (51 trials)
icosapent ethyl (vascepa) (1 trial)
idarubicin (idamycin) (1 trial)
irinotecan (Camptosar) (29 trials)
lenvatinib (lenvima) (18 trials)
levoleucovorin (fusilev) (1 trial)
megakaryocytic progenitor cells (1 trial)
melphalan (alkeran) (3 trials)
methylprednisolone (medrol) (10 trials)
mitomycin (mutamycin) (3 trials)
monosialoganglioside (1 trial)
monosialotetrahexosyl ganglioside (4 trials)
moxifloxacin (avelox) (4 trials)
nitric oxide (inomax) (1 trial)
olanzapine (zyprexa) (2 trials)
oprelvekin (Neumega) (2 trials)
osimertinib (tagrisso) (7 trials)
oxaliplatin (eloxatin) (87 trials)
paclitaxel (taxol) (70 trials)
palonosetron (aloxi) (3 trials)
pegaspargase (oncaspar) (12 trials)
pemetrexed (alimta) (23 trials)
pertuzumab (perjeta) (4 trials)
progesterone (progestasert) (4 trials)
propranolol (inderal) (1 trial)
recombinant human adenovirus type 5 (1 trial)
recombinant human choriogonadotropin alfa (Ovidrel) (2 trials)
ribavirin (virazole) (3 trials)
rifaximin (xifaxan) (2 trials)
sargramostim (leukine) (4 trials)
silver diammine fluoride (1 trial)
sirolimus (rapamune) (1 trial)
temozolomide (temodar) (9 trials)
topotecan (hycamtin) (1 trial)
toremifene (fareston) (2 trials)
trastuzumab (herceptin) (15 trials)
tripterygium wilfordii (1 trial)
triptorelin (Trelstar) (1 trial)
umbilical cord mesenchymal stem cells (12 trials)
ursodeoxycholic acid (1 trial)
ursodeoxycholyltaurine (1 trial)
vinorelbine (navelbine) (14 trials)
1,4-butanethiosulfonate (1 trial)
ademetionine1,4-butanethiosulfonate (1 trial)
albumin (Human) (Plasbumin) (1 trial)
allogeneic adipose derived mesenchymal stem cell (2 trials)
allogeneic cord blood (1 trial)
allogeneic hematopoietic stem cells (Hemacord) (5 trials)
allogeneic lymphocytes (1 trial)
allogeneic stem cells (1 trial)
anastrozole (arimidex) (1 trial)
asparaginase (elspar) (3 trials)
autologous cik cells (1 trial)
autologous cytokine induced killer cells (1 trial)
autologous dendritic cells (1 trial)
azithromycin (zithromax) (1 trial)
bacillus mesentericus jpc (1 trial)
basiliximab (simulect) (1 trial)
bendamustine (treanda) (1 trial)
betamethasone (celestone) (2 trials)
bone marrow derived mesenchymal stem cells (1 trial)
bromocriptine (parlodel) (2 trials)
cd44v6-specific car gene-engineered t cells (1 trial)
cladribine (leustatin) (3 trials)
clarithromycin (biaxin) (2 trials)
clostridium butyricum (1 trial)
cyanocobalamin (berocca) (3 trials)
daunorubicin (cerubidine) (1 trial)
dendritic cell activated cytokine-induced killer cell (1 trial)
desloratadine (clarinex) (1 trial)
durvalumab (imfinzi) (1 trial)
edaravone (radicava) (3 trials)
everolimus (zortress) (2 trials)
gentamicin (garamycin) (1 trial)
granisetron (kytril) (1 trial)
human placental derived stem cells (1 trial)
ibrutinib (imbruvica) (1 trial)
interferon alpha-2a (roferon-a) (7 trials)
itraconazole (sporanox) (1 trial)
lanreotide (somatuline depot) (1 trial)
lenalidomide (revlimid) (5 trials)
levofloxacin (levaquin) (1 trial)
masct:multiple antigens specific cellular therapy (1 trial)
minocycline (minocin) (1 trial)
mirtazapine (remeron) (1 trial)
multiple sarcoma-specific car-t cells (1 trial)
multiple signals loaded dendritic cells vaccine (1 trial)
ondansetron (zofran) (1 trial)
palbociclib (ibrance) (2 trials)
pembrolizumab (keytruda) (4 trials)
pomalidomide (pomalyst) (1 trial)
potassium chloride (klor-con) (1 trial)
procaine merethoxylline (1 trial)
regorafenib (stivarga) (3 trials)
streptococcus faecalis jpc (1 trial)
trolamine polypeptide oleate condensate (cerumenex) (1 trial)
tumour infiltrating lymphocytes (2 trials)
umbilical mesenchymal stem cells derived exosomes (1 trial)
vemurafenib (zelboraf) (1 trial)
venetoclax (venclexta) (1 trial)
acetaminophen (tylenol) (1 trial)
aldesleukin (proleukin) (2 trials)
chimeric antigen receptor t cells, eps8 or wt1 peptide specific dendritic cell (1 trial)
cxcr5 modified egfr chimeric antigen receptor autologous t cells (1 trial)
daclatasvir (daklinza) (2 trials)
dendritic cells loaded with 17 antigens (1 trial)
encorafenib (braftovi) (1 trial)
endostatin adenovirus (1 trial)
genetically engineered ny-eso-1-specific t lymphocytes (1 trial)
hiv-specific cd8 cells (1 trial)
indocyanine green (ic-green) (3 trials)
lmp2 antigen-specific tcr t cells (1 trial)
amantadine (symmetrel) (1 trial)
artemisiacapillaris thunb (1 trial)
benazepril (lotensin) (1 trial)
brimonidine (alphagan) (1 trial)
brinzolamide (azopt) (1 trial)
carboprost tromethamine (hemabate) (1 trial)
carboxypolymethylene (1 trial)
ciprofloxacin (cipro) (1 trial)
clindamycin (cleocin) (1 trial)
dehydroepiandrosterone (1 trial)
desflurane (suprane) (1 trial)
diclofenac (voltaren) (1 trial)
dipyridamole (persantine) (1 trial)
ethambutol (myambutol) (1 trial)
flurbiprofen (ansaid) (2 trials)
ganciclovir (cytovene) (1 trial)
gardenia jasminoides ellis (1 trial)
isoniazid (nydrazid) (1 trial)
lactobacillus paracasei (2 trials)
latanoprost (xalatan) (1 trial)
menopausal gonadotropin (1 trial)
metronidazole (flagyl) (3 trials)
nalbuphine (nubain) (2 trials)
norepinephrine (levophed) (2 trials)
omega-3 fatty acids (omacor) (1 trial)
oxycodone (oxycontin) (1 trial)
oxytocin (syntocinon) (1 trial)
peginterferon beta-1a (Plegridy) (1 trial)
pilocarpine (ocusert) (1 trial)
proparacaine (ophthaine) (3 trials)
pyrazinamide (Aldinamide) (1 trial)
salviae miltiorrhizae radix (1 trial)
salvia miltiorrhiza extract (1 trial)
sieyesbeckiaorientalis (1 trial)
simvastatin (zocor) (3 trials)
sodium potassium pyrophosphate (1 trial)
tranexamic acid (cyklokapron) (1 trial)
triamcinolone (kenalog) (1 trial)
tropicamide (mydriacyl) (1 trial)
urofollitropin (metrodin) (1 trial)
valproic acid (depakene) (1 trial)
vandetanib (caprelsa) (1 trial)
verteporfin (visudyne) (1 trial)
Acquired Immunodeficiency Syndrome (Phase 1)
Acromegaly (Phase 2)
Acute Coronary Syndrome (Phase 4)
Acute Disease (Phase 3)
Acute Lung Injury (Phase 1)
Acute-On-Chronic Liver Failure (Phase 2)
Adenocarcinoma (Phase 3)
Adenocarcinoma of Lung (Phase 2)
Adenoviridae Infections (Phase 3)
Albuminuria (Phase 4)
Alzheimer Disease (Phase 2)
Anastomotic Leak (Phase 3)
Anemia (Phase 2)
Anemia, Aplastic (Phase 2)
Aneurysm (Phase 4)
Ankylosis (Phase 3)
Aortic Aneurysm (Phase 4)
Arteriosclerosis (Phase 4)
Arteriosclerosis Obliterans (Phase 4)
Arteriovenous Malformations (Phase 4)
Arthritis (Phase 4)
Arthritis, Rheumatoid (Phase 4)
Asthma (Phase 4)
Astrocytoma (Phase 3)
Atrial Fibrillation (Phase 4)
Atrophic Vaginitis (Phase 1)
Atrophy (Phase 1)
Autoimmune Diseases (Phase 2)
Biliary Tract Neoplasms (Phase 2)
Bone Diseases (Phase 3)
Bone Marrow Diseases (Phase 4)
Bone Neoplasms (Phase 4)
Brain Injuries (Phase 2)
Brain Neoplasms (Phase 3)
Breast Diseases (Phase 2)
Breast Neoplasms (Phase 4)
Bronchial Neoplasms (Phase 2)
Bronchiolitis (Phase 2)
Bronchiolitis Obliterans (Phase 2)
Bronchopulmonary Dysplasia (Phase 3)
Burns (Phase 3)
Carcinoma (Phase 4)
Carcinoma, Ductal (Phase 3)
Carcinoma, Ductal, Breast (Phase 3)
Carcinoma, Hepatocellular (Phase 4)
Carcinoma in Situ (Phase 3)
Carcinoma, Intraductal, Noninfiltrating (Phase 3)
Carcinoma, Non-Small-Cell Lung (Phase 4)
Carcinoma, Ovarian Epithelial (Phase 3)
Carcinoma, Renal Cell (Phase 2)
Carcinoma, Small Cell (Phase 2)
Carcinoma, Squamous Cell (Phase 3)
Carcinoma, Transitional Cell (Phase 2)
Cardiomyopathies (Phase 2)
Cardiovascular Diseases (Phase 4)
Carotid Stenosis (Phase 2)
Cerebral Infarction (Phase 2)
Cerebral Small Vessel Diseases (Phase 4)
Cholangiocarcinoma (Phase 3)
Cholestasis (Phase 3)
Choroidal Neovascularization (Phase 4)
Cognitive Dysfunction (Phase 4)
Colitis (Phase 2)
Colitis, Ulcerative (Phase 2)
Colonic Neoplasms (Phase 3)
Colorectal Neoplasms (Phase 3)
Communicable Diseases (Phase 2)
Conjunctivitis, Allergic (Phase 4)
Constipation (Phase 3)
Constriction, Pathologic (Phase 2)
Corneal Diseases (Phase 2)
Coronavirus Infections (Phase 2)
Crohn Disease (Phase 3)
Cytomegalovirus Infections (Phase 2)
Death (Phase 1)
Delayed Emergence from Anesthesia (Phase 4)
Delirium (Phase 4)
Dental Caries (Phase 3)
Depression (Phase 2)
Depressive Disorder (Phase 2)
Dermatitis (Phase 2)
Diabetes Mellitus (Phase 4)
Diabetes Mellitus, Type 1 (Phase 4)
Diabetes Mellitus, Type 2 (Phase 4)
Diabetic Nephropathies (Phase 4)
Diabetic Retinopathy (Phase 1)
Diarrhea (Phase 2)
Digestive System Neoplasms (Phase 3)
Dilatation, Pathologic (Phase 2)
Disease (Phase 4)
Disseminated Intravascular Coagulation (Phase 3)
Dry Eye Syndromes (Phase 4)
Dwarfism, Pituitary (Phase 4)
Dyslipidemias (Phase 4)
Edema (Phase 2)
Emergence Delirium (Phase 4)
Endocarditis (Phase 4)
Endocrine System Diseases (Phase 4)
Endometrial Neoplasms (Phase 2)
End Stage Liver Disease (Phase 2)
Esophageal and Gastric Varices (Phase 3)
Esophageal Neoplasms (Phase 3)
Esophageal Squamous Cell Carcinoma (Phase 3)
Exophthalmos (Phase 3)
Eye Burns (Phase 3)
Eye Diseases (Phase 3)
Eye Diseases, Hereditary (Phase 2)
Fallopian Tube Neoplasms (Phase 3)
Fatty Liver (Phase 4)
Fibrosis (Phase 4)
Fistula (Phase 3)
Gangliosidoses (Phase 3)
Gangliosidosis, GM1 (Phase 3)
Gastroesophageal Reflux (Phase 3)
Gastrointestinal Neoplasms (Phase 3)
Gastrointestinal Stromal Tumors (Phase 2)
Genetic Diseases, Inborn (Phase 2)
Gestational Trophoblastic Disease (Phase 3)
Glaucoma (Phase 2)
Glaucoma, Neovascular (Phase 2)
Glaucoma, Open-Angle (Phase 2)
Glioblastoma (Phase 3)
Glioma (Phase 3)
Glomerulonephritis (Phase 2)
Glomerulonephritis, IGA (Phase 4)
Glomerulonephritis, Membranous (Phase 2)
Glucose Metabolism Disorders (Phase 4)
Graft vs Host Disease (Phase 4)
Graves Disease (Phase 2)
Graves Ophthalmopathy (Phase 3)
Hand-Foot Syndrome (Phase 4)
Headache (Phase 4)
Head and Neck Neoplasms (Phase 4)
Hemangioma (Phase 1)